CD4 and neoplasm: Given that RNase1 increases cell frequencies of CD4+ Th1, Th17, and NK cells (Figure 2 and 3), it is possible that RNase1 increases CD4+ T cell-specific subsets, which in turn activate NK cell function to generate a more robust immune response for eradicating tumor cells.